Buscar
CareDx Inc
CDNAAñadir a la lista de seguimiento
28.931USD
-0.319-1.09%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
1.49BCap. mercado
PérdidaP/E TTM
Más Datos de CareDx Inc Compañía
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
Información de CareDx Inc
Símbolo de cotizaciónCDNA
Nombre de la empresaCareDx Inc
Fecha de salida a bolsaJul 17, 2014
Director ejecutivoHanna (John W)
Número de empleados644
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 17
Dirección8000 Marina Blvd
CiudadBRISBANE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94005
Teléfono14152872300
Sitio Webhttps://www.caredx.com/
Símbolo de cotizaciónCDNA
Fecha de salida a bolsaJul 17, 2014
Director ejecutivoHanna (John W)
Ejecutivos de CareDx Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
157.13K
+6.23%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
46.84K
+20.91%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
37.72K
-3.42%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
37.25K
+26.30%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
28.79K
-25.66%
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
8.17K
-867.03%
Mr. George W. Bickerstaff, III
Mr. George W. Bickerstaff, III
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
157.13K
+6.23%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
46.84K
+20.91%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
37.72K
-3.42%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de CareDx Inc?
Los cinco principales accionistas de CareDx Inc son: Dr. Peter Maag, Ph.D.
¿Cuántas instituciones poseen acciones de CareDx Inc (CDNA)?
A fecha de 2026Q1, 469 instituciones poseen acciones de CareDx Inc, con un valor de mercado combinado de aproximadamente 52.46M, lo que representa el 101.54% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -9782235.00.
¿Cuál es la mayor fuente de ganancias de CareDx Inc?
El 2026Q1, el segmento empresarial Testing Service revenue generó la ganancia más alta para CareDx Inc, ascendiendo a 274.50M y representando el 72.27% de la ganancia total.